Surmodics ROA 2010-2024 | SRDX
Current and historical return on assets (ROA) values for Surmodics (SRDX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Surmodics ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-12-31 | $-0.02B | $0.16B | -8.53% |
| 2024-09-30 | $-0.01B | $0.18B | -6.68% |
| 2024-06-30 | $-0.00B | $0.18B | -1.10% |
| 2024-03-31 | $0.01B | $0.18B | 7.05% |
| 2023-12-31 | $0.01B | $0.18B | 2.77% |
| 2023-09-30 | $-0.00B | $0.19B | -1.13% |
| 2023-06-30 | $-0.02B | $0.19B | -14.06% |
| 2023-03-31 | $-0.04B | $0.17B | -22.09% |
| 2022-12-31 | $-0.03B | $0.17B | -19.19% |
| 2022-09-30 | $-0.03B | $0.16B | -15.93% |
| 2022-06-30 | $-0.01B | $0.18B | -7.03% |
| 2022-03-31 | $-0.01B | $0.18B | -5.40% |
| 2021-12-31 | $0.00B | $0.19B | 1.09% |
| 2021-09-30 | $0.01B | $0.20B | 2.81% |
| 2021-06-30 | $0.00B | $0.18B | 1.16% |
| 2021-03-31 | $0.01B | $0.18B | 4.14% |
| 2020-12-31 | $0.00B | $0.16B | 0.00% |
| 2020-09-30 | $0.00B | $0.17B | 0.00% |
| 2020-06-30 | $0.01B | $0.17B | 4.40% |
| 2020-03-31 | $0.01B | $0.16B | 3.86% |
| 2019-12-31 | $0.01B | $0.16B | 3.90% |
| 2019-09-30 | $0.01B | $0.16B | 4.58% |
| 2019-06-30 | $0.00B | $0.15B | 0.65% |
| 2019-03-31 | $-0.00B | $0.15B | -1.92% |
| 2018-12-31 | $-0.00B | $0.15B | -1.25% |
| 2018-09-30 | $-0.01B | $0.16B | -3.22% |
| 2018-06-30 | $-0.00B | $0.16B | -2.02% |
| 2018-03-31 | $0.00B | $0.16B | 0.71% |
| 2017-12-31 | $0.00B | $0.14B | 0.00% |
| 2017-09-30 | $0.00B | $0.14B | 3.02% |
| 2017-06-30 | $0.01B | $0.13B | 5.33% |
| 2017-03-31 | $0.01B | $0.13B | 7.69% |
| 2016-12-31 | $0.01B | $0.13B | 7.83% |
| 2016-09-30 | $0.01B | $0.13B | 8.91% |
| 2016-06-30 | $0.01B | $0.13B | 7.83% |
| 2016-03-31 | $0.01B | $0.12B | 8.39% |
| 2015-12-31 | $0.01B | $0.11B | 11.06% |
| 2015-09-30 | $0.01B | $0.10B | 12.87% |
| 2015-06-30 | $0.01B | $0.10B | 13.72% |
| 2015-03-31 | $0.01B | $0.09B | 13.54% |
| 2014-12-31 | $0.01B | $0.09B | 12.34% |
| 2014-09-30 | $0.01B | $0.11B | 12.09% |
| 2014-06-30 | $0.01B | $0.10B | 14.21% |
| 2014-03-31 | $0.01B | $0.10B | 13.10% |
| 2013-12-31 | $0.02B | $0.10B | 14.67% |
| 2013-09-30 | $0.02B | $0.10B | 14.22% |
| 2013-06-30 | $0.01B | $0.10B | 13.21% |
| 2013-03-31 | $0.01B | $0.11B | 11.72% |
| 2012-12-31 | $0.01B | $0.11B | 9.16% |
| 2012-09-30 | $0.01B | $0.10B | 7.75% |
| 2012-06-30 | $-0.01B | $0.16B | -7.09% |
| 2012-03-31 | $-0.01B | $0.15B | -6.29% |
| 2011-12-31 | $-0.01B | $0.15B | -6.12% |
| 2011-09-30 | $-0.02B | $0.16B | -11.28% |
| 2011-06-30 | $-0.02B | $0.17B | -12.81% |
| 2011-03-31 | $-0.03B | $0.17B | -15.32% |
| 2010-12-31 | $-0.03B | $0.17B | -16.02% |
| 2010-09-30 | $-0.02B | $0.17B | -11.31% |
| 2010-06-30 | $0.00B | $0.19B | 2.11% |
| 2010-03-31 | $0.01B | $0.19B | 4.80% |
| 2009-12-31 | $0.01B | $0.19B | 7.02% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.492B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.977B | 28.52 |
| Boston Scientific (BSX) | United States | $155.488B | 41.98 |
| Stryker (SYK) | United States | $147.446B | 31.70 |
| EssilorLuxottica (ESLOY) | France | $140.780B | 0.00 |
| Medtronic (MDT) | Ireland | $112.764B | 16.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.084B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.818B | 29.12 |
| GE HealthCare Technologies (GEHC) | United States | $42.113B | 20.51 |
| Agilent Technologies (A) | United States | $39.025B | 25.86 |
| ResMed (RMD) | United States | $34.189B | 26.33 |
| Terumo (TRUMY) | Japan | $26.310B | 37.41 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 16.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.630B | 12.95 |
| Insulet (PODD) | United States | $20.222B | 86.57 |
| Baxter (BAX) | United States | $17.074B | 12.34 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.245B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.513B | 35.65 |
| Bio-Rad Laboratories (BIO) | United States | $8.001B | 27.70 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 13.06 |
| Prestige Consumer Healthcare (PBH) | United States | $4.200B | 20.05 |
| ICU Medical (ICUI) | United States | $3.995B | 38.03 |
| Envista Holdings (NVST) | United States | $3.693B | 29.38 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.188B | 15.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.921B | 19.69 |
| QuidelOrtho (QDEL) | United States | $2.760B | 23.18 |
| LeMaitre Vascular (LMAT) | United States | $2.269B | 55.15 |
| Neogen (NEOG) | United States | $2.178B | 25.10 |
| AtriCure (ATRC) | United States | $1.914B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.484B | 25.90 |
| InMode (INMD) | Israel | $1.320B | 11.03 |
| BioLife Solutions (BLFS) | United States | $1.276B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.180B | 8.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.997B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.938B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.930B | 14.27 |
| Evolus (EOLS) | United States | $0.926B | 0.00 |
| CeriBell (CBLL) | United States | $0.828B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.689B | 0.00 |
| Valneva SE (VALN) | France | $0.643B | 0.00 |
| Omeros (OMER) | United States | $0.557B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.529B | 22.95 |
| Owens & Minor (OMI) | United States | $0.494B | 3.86 |
| SNDL (SNDL) | Canada | $0.462B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.373B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.321B | 58.60 |
| Viemed Healthcare (VMD) | United States | $0.310B | 29.52 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.289B | 19.40 |
| Biote (BTMD) | United States | $0.260B | 5.69 |
| Canopy Growth (CGC) | Canada | $0.250B | 0.00 |
| Zynex (ZYXI) | United States | $0.236B | 49.40 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| Brainsway (BWAY) | Israel | $0.212B | 112.80 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 15.39 |
| MacroGenics (MGNX) | United States | $0.181B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.51 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 12.79 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| InterCure (INCR) | Israel | $0.075B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Exagen (XGN) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.058B | 30.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| MariMed (MRMD) | United States | $0.050B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.22 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| INLIF (INLF) | $0.040B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |